Actively Recruiting
Study to Validate a New Prediction Model for Kidney Cancer Treatment and Outcomes Including Patients With Venous Tumor Thrombus Using Real-World Data and Risk-Based Treatment Comparison
Led by Peking University Third Hospital · Updated on 2026-04-14
4700
Participants Needed
1
Research Sites
25 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a single-center observational study using real-world data from 4700 patients with renal cell carcinoma RCC, including those with venous tumor thrombus VTT, treated at Peking University Third Hospital. The study aims to develop and validate a new prognostic prediction model for RCC patients, compare its performance against existing models, and assess whether risk-stratified treatment based on this model can improve survival outcomes using an emulated target trial approach. The study includes two main groups patients receiving treatment aligned with the risk stratification from the new prediction model, and those whose treatment does not follow this stratification. Treatments evaluated include model-guided adjuvant therapies initiated within 12 weeks after surgery or no adjuvant treatment during follow-up before disease progression. Data is collected retrospectively from 2012 to 2025 and prospectively from 2025 to 2026, covering clinical, laboratory, imaging, pathology, and treatment information. Participants undergo follow-up visits and telephone check-ins based on European Association of Urology guidelines until events such as recurrence, death, withdrawal, or study completion. Researchers monitor survival, disease recurrence, quality of life, and healthcare resource use. The primary outcome is disease-free survival measured up to 48 months from follow-up start to recurrence, second primary cancer, death, or other events. Data quality assurance and statistical analyses are performed to evaluate model performance and treatment effects.
CONDITIONS
Brief Title
Validation of RCC Predicting Model With Emulated-target Trial
Research Team
J
Jiyuan Chen, master
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here